The clinical radiobiology of breast cancer radiotherapy

Editorial

John M Kurtz. Radiother Oncol. 2005 Apr.

. 2005 Apr;75(1):6-8.

doi: 10.1016/j.radonc.2005.03.017. Epub 2005 Apr 18.

No abstract available

Comment on

Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.
Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, Haviland J, Bentzen S, Owen R. Yarnold J, et al. Radiother Oncol. 2005 Apr;75(1):9-17. doi: 10.1016/j.radonc.2005.01.005. Epub 2005 Mar 16. Radiother Oncol. 2005. PMID: 15878095 Clinical Trial.
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer.
Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J, Owen R, Homewood J, Bliss J, Yarnold J. Andreassen CN, et al. Radiother Oncol. 2005 Apr;75(1):18-21. doi: 10.1016/j.radonc.2004.12.012. Radiother Oncol. 2005. PMID: 15878096